See more : IceCure Medical Ltd (ICCM.TA) Income Statement Analysis – Financial Results
Complete financial analysis of Spectral AI, Inc. (MDAI) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Spectral AI, Inc., a leading company in the Medical – Devices industry within the Healthcare sector.
- Growth Capital Acquisition Corp. (GCAC) Income Statement Analysis – Financial Results
- Golar LNG Limited (GLNG) Income Statement Analysis – Financial Results
- Bayerische Motoren Werke Aktiengesellschaft (BMW3.DE) Income Statement Analysis – Financial Results
- Doosan Fuel Cell Co., Ltd. (336260.KS) Income Statement Analysis – Financial Results
- Grifols, S.A. (GRF.MC) Income Statement Analysis – Financial Results
Spectral AI, Inc. (MDAI)
About Spectral AI, Inc.
Spectral AI, Inc. operates as an artificial intelligence (AI) company. The company focuses on medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers. Its products include DeepView, a predictive diagnostic device that offers clinicians an objective and immediate assessment of a wound's healing potential prior to treatment or other medical intervention. The company is based in Dallas, Texas.
Metric | 2023 | 2022 | 2021 |
---|---|---|---|
Revenue | 18.06M | 25.37M | 15.24M |
Cost of Revenue | 10.18M | 14.53M | 8.19M |
Gross Profit | 7.88M | 10.84M | 7.05M |
Gross Profit Ratio | 43.64% | 42.72% | 46.28% |
Research & Development | 0.00 | 0.00 | 0.00 |
General & Administrative | 20.86M | 13.48M | 11.23M |
Selling & Marketing | 0.00 | 0.00 | 0.00 |
SG&A | 20.86M | 13.48M | 11.23M |
Other Expenses | 0.00 | 49.00K | 0.00 |
Operating Expenses | 20.86M | 13.48M | 11.23M |
Cost & Expenses | 31.04M | 28.02M | 19.42M |
Interest Income | 172.00K | 21.00K | 0.00 |
Interest Expense | 0.00 | 0.00 | 0.00 |
Depreciation & Amortization | 722.00K | 568.00K | 1.00K |
EBITDA | -12.26M | -2.08M | -4.18M |
EBITDA Ratio | -67.91% | -7.42% | -28.14% |
Operating Income | -12.98M | -2.65M | -4.18M |
Operating Income Ratio | -71.91% | -10.43% | -27.42% |
Total Other Income/Expenses | -7.86M | -159.00K | 93.00K |
Income Before Tax | -20.84M | -2.81M | -4.09M |
Income Before Tax Ratio | -115.44% | -11.06% | -26.81% |
Income Tax Expense | 11.00K | 106.00K | -98.00K |
Net Income | -20.85M | -2.91M | -3.99M |
Net Income Ratio | -115.50% | -11.48% | -26.17% |
EPS | -1.48 | -0.16 | -0.22 |
EPS Diluted | -1.48 | -0.16 | -0.22 |
Weighted Avg Shares Out | 14.09M | 17.88M | 17.88M |
Weighted Avg Shares Out (Dil) | 14.09M | 17.88M | 17.88M |
Spectral AI wins US government contract to develop handheld DeepView wound imaging system
Spectral AI Announces New US Government Contract to Further Accelerate the Development of the Handheld Version of DeepView™ Wound Imaging System
Spectral AI to advance AI-driven healthcare solutions through new subsidiary
Spectral AI Announces Intellectual Property Subsidiary to Focus on the Broader AI Healthcare Ecosystem
Spectral AI Appoints Peter M. Carlson as CEO
Spectral AI to Participate in Upcoming Investor Conferences
Spectral AI sees revenue starting in 2024 from DeepView burn diagnosis system after securing UKCA Authorization
Spectral Receives UKCA Authorization for Burn Indication Expected Commercialization 2nd Half 2024
Forget Nvidia: AI stocks with significant growth potential to watch
Spectral AI founder and ex-boss returns as director
Source: https://incomestatements.info
Category: Stock Reports